where chemotherapy medications are flushed in. Immunotherapy. Some people with certain types of bladder cancer may respond to immunotherapy. Immunotherapy medications help your immune system ...

Adding an ICI to neoadjuvant chemotherapy can improve pCR rates and may improve OS in patients with MIBC, research suggests.

When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

This drug for breast cancer was the first ... For 30 years the standard of care for this type of bladder cancer was chemotherapy alone, says oncologist David J. Benjamin, who treats genitourinary ...

From a biomarker-driven strategy to delay or avoid cystectomy, to practice-changing perioperative immunotherapy, developments ...

enhancing chemotherapy delivery in advanced bladder cancer. New predictive tools are necessary to optimize therapy selection as treatment landscapes evolve, potentially improving patient outcomes.

An international trial found combining a chemotherapy drug with an immunotherapy bladder cancer treatment is simple, safe and ...

Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

A new review was published in Volume 16 of Oncotarget on May 19, 2025, titled "Advancements in bladder cancer treatment: The ...

In the CheckMate 274 study, adjuvant nivolumab demonstrated a significant improvement in disease-free survival (DFS) and showed a trend toward improved overall survival (OS) in an unselected ...

Introduction Oncology drugs are medications used to prevent or treat cancer. These include chemotherapy, targeted therapy, immunotherapy, and h ...